Literature DB >> 27195474

Multiparametric human hepatocellular carcinoma characterization and therapy response evaluation by hyperpolarized (13) C MRSI.

Stephan Düwel1,2, Markus Durst1, Concetta V Gringeri3, Yvonne Kosanke4, Claudia Gross4, Martin A Janich5, Axel Haase1, Steffen J Glaser2, Markus Schwaiger3, Rolf F Schulte5, Rickmer Braren4, Marion I Menzel5.   

Abstract

Individual tumor characterization and treatment response monitoring based on current medical imaging methods remain challenging. This work investigates hyperpolarized (13) C compounds in an orthotopic rat hepatocellular carcinoma (HCC) model system before and after transcatheter arterial embolization (TAE). HCC ranks amongst the top six most common cancer types in humans and accounts for one-third of cancer-related deaths worldwide. Early therapy response monitoring could aid in the development of personalized therapy approaches and novel therapeutic concepts. Measurements with selectively (13) C-labeled and hyperpolarized urea, pyruvate and fumarate were performed in tumor-bearing rats before and after TAE. Two-dimensional, slice-selective MRSI was used to obtain spatially resolved maps of tumor perfusion, cell energy metabolic conversion rates and necrosis, which were additionally correlated with immunohistochemistry. All three injected compounds, taken together with their respective metabolites, exhibited similar signal distributions. TAE induced a decrease in blood flow into the tumor and thus a decrease in tumor to muscle and tumor to liver ratios of urea, pyruvate and its metabolites, alanine and lactate, whereas conversion rates remained stable or increased on TAE in tumor, muscle and liver tissue. Conversion from fumarate to malate successfully indicated individual levels of necrosis, and global malate signals after TAE suggested the washout of fumarase or malate itself on necrosis. This study presents a combination of three (13) C compounds as novel candidate biomarkers for a comprehensive characterization of genetically and molecularly diverse HCC using hyperpolarized MRSI, enabling the simultaneous detection of differences in tumor perfusion, metabolism and necrosis. If, as in this study, bolus dynamics are not required and qualitative perfusion information is sufficient, the desired information could be extracted from hyperpolarized fumarate and pyruvate alone, acquired at higher fields with better spectral separation.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cancer therapy responses; hepatobiliary cancers; hyperpolarized 13C; spectroscopic imaging

Mesh:

Substances:

Year:  2016        PMID: 27195474     DOI: 10.1002/nbm.3561

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  13 in total

1.  Functional Genetic Screening Enables Theranostic Molecular Imaging in Cancer.

Authors:  Nicholas R Perkons; Omar Johnson; Gabrielle Pilla; Enri Profka; Michael Mercadante; Daniel Ackerman; Terence P F Gade
Journal:  Clin Cancer Res       Date:  2020-06-04       Impact factor: 12.531

Review 2.  The use of hyperpolarized carbon-13 magnetic resonance for molecular imaging.

Authors:  Sarmad Siddiqui; Stephen Kadlecek; Mehrdad Pourfathi; Yi Xin; William Mannherz; Hooman Hamedani; Nicholas Drachman; Kai Ruppert; Justin Clapp; Rahim Rizi
Journal:  Adv Drug Deliv Rev       Date:  2016-09-04       Impact factor: 15.470

Review 3.  Magnetic resonance imaging with hyperpolarized agents: methods and applications.

Authors:  Erin B Adamson; Kai D Ludwig; David G Mummy; Sean B Fain
Journal:  Phys Med Biol       Date:  2017-04-06       Impact factor: 3.609

Review 4.  Hyperpolarized 13C MRI: State of the Art and Future Directions.

Authors:  Zhen J Wang; Michael A Ohliger; Peder E Z Larson; Jeremy W Gordon; Robert A Bok; James Slater; Javier E Villanueva-Meyer; Christopher P Hess; John Kurhanewicz; Daniel B Vigneron
Journal:  Radiology       Date:  2019-03-05       Impact factor: 11.105

5.  Detecting liver injury non-invasively using hyperpolarized 13 C MRI.

Authors:  Cornelius von Morze
Journal:  Liver Int       Date:  2018-06       Impact factor: 5.828

6.  Hyperpolarized 13C Diffusion MRS of Co-Polarized Pyruvate and Fumarate to Measure Lactate Export and Necrosis.

Authors:  Benedikt Feuerecker; Markus Durst; Michael Michalik; Günter Schneider; Dieter Saur; Marion Menzel; Markus Schwaiger; Franz Schilling
Journal:  J Cancer       Date:  2017-09-02       Impact factor: 4.207

Review 7.  Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology.

Authors:  John Kurhanewicz; Daniel B Vigneron; Jan Henrik Ardenkjaer-Larsen; James A Bankson; Kevin Brindle; Charles H Cunningham; Ferdia A Gallagher; Kayvan R Keshari; Andreas Kjaer; Christoffer Laustsen; David A Mankoff; Matthew E Merritt; Sarah J Nelson; John M Pauly; Philips Lee; Sabrina Ronen; Damian J Tyler; Sunder S Rajan; Daniel M Spielman; Lawrence Wald; Xiaoliang Zhang; Craig R Malloy; Rahim Rizi
Journal:  Neoplasia       Date:  2018-11-23       Impact factor: 5.715

8.  Assessment of 213Bi-anti-EGFR MAb treatment efficacy in malignant cancer cells with [1-13C]pyruvate and [18F]FDG.

Authors:  Benedikt Feuerecker; Michael Michalik; Christian Hundshammer; Markus Schwaiger; Frank Bruchertseifer; Alfred Morgenstern; Christof Seidl
Journal:  Sci Rep       Date:  2019-06-05       Impact factor: 4.379

Review 9.  Acquisition strategies for spatially resolved magnetic resonance detection of hyperpolarized nuclei.

Authors:  Geoffrey J Topping; Christian Hundshammer; Luca Nagel; Martin Grashei; Maximilian Aigner; Jason G Skinner; Rolf F Schulte; Franz Schilling
Journal:  MAGMA       Date:  2019-12-06       Impact factor: 2.310

10.  Monitoring tumor cell death in murine tumor models using deuterium magnetic resonance spectroscopy and spectroscopic imaging.

Authors:  Friederike Hesse; Vencel Somai; Felix Kreis; Flaviu Bulat; Alan J Wright; Kevin M Brindle
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-23       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.